Response to Comment on "The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility"

Affiliations

¹ Department Public and Occupational Health/Coronel Institute of Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. m.a.greidanus@amsterdamumc.nl.
² Department Public and Occupational Health/Coronel Institute of Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
³ Department of Social Medicine, Faculty of Health, Medicine and Life Sciences, Research Institute Primary Care and Public Health (CAPHRI), Maastricht University, Duboisdomein 30, Maastricht, The Netherlands.

Comment

Michiel A Greidanus et al. Patient. 2021 Jan.

. 2021 Jan;14(1):141-143.

doi: 10.1007/s40271-020-00472-1. Epub 2020 Oct 19.

¹ Department Public and Occupational Health/Coronel Institute of Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. m.a.greidanus@amsterdamumc.nl.
² Department Public and Occupational Health/Coronel Institute of Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
³ Department of Social Medicine, Faculty of Health, Medicine and Life Sciences, Research Institute Primary Care and Public Health (CAPHRI), Maastricht University, Duboisdomein 30, Maastricht, The Netherlands.

No abstract available

Keywords: Cancer; Questionnaire; Reproducibility; Return to work; Validity.

Comment on

The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility.
Greidanus MA, de Boer AGEM, de Rijk AE, Brouwers S, de Reijke TM, Kersten MJ, Klinkenbijl JHG, Lalisang RI, Lindeboom R, Zondervan PJ, Frings-Dresen MHW, Tamminga SJ. Greidanus MA, et al. Patient. 2020 Oct;13(5):567-582. doi: 10.1007/s40271-020-00427-6. Patient. 2020. PMID: 32508005 Free PMC article.
Letter to the Editor in response to Greidanus et al., June 2020, "The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility".
Kobayashi M, Kako J, Kajiwara K, Ogata A. Kobayashi M, et al. Patient. 2021 Jan;14(1):139-140. doi: 10.1007/s40271-020-00470-3. Epub 2020 Oct 19. Patient. 2021. PMID: 33073337 No abstract available.

1. Kobayashi M, et al. Letter to the Editor in response to Greidanus et al. “The successful return-to-work questionnaire for cancer survivors (I-RTW_CS): development, validity and reproducibility”. Patient Patient-Center Outcomes Res. 2020. https://doi.org/10.1007/s40271-020-00470-3 . - DOI
1. Greidanus MA, et al. The Successful return-to-work questionnaire for cancer survivors (I-RTW_CS): development, validity and reproducibility. Patient Patient-Center Outcomes Res. 2020;13(5):567–82. - DOI
1. Johnson C et al. EORTC quality of life group: guidelines for developing questionnaires modules. EORTC. 2011. https://www.eortc.org/app/uploads/sites/2/2018/02/guidelines_for_develop... . Accessed 27 Sept 2020.
1. de Boer AG, et al. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2015;2015(9):007569.
1. Islam T, et al. Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health. 2014;14(Suppl 3):S8. - DOI